Pasha Apontes, Ph.D.
Affiliations: | 2011 | Roswell Park . Cellular and Molecular Biology | State University of New York, Buffalo, Buffalo, NY, United States |
Area:
Molecular Biology, OncologyGoogle:
"Pasha Apontes"Parents
Sign in to add mentor| Fengzhi Li | grad student | 2011 | SUNY Buffalo | |
| (Reduced glucose signaling and downregulation of survivin as potential anticancer therapeutic strategies.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Apontes P, Leontieva OV, Demidenko ZN, et al. (2011) Exploring long-term protection of normal human fibroblasts and epithelial cells from chemotherapy in cell culture. Oncotarget. 2: 222-33 |
| Ling X, He X, Apontes P, et al. (2009) Enhancing effectiveness of the MDR-sensitive compound T138067 using advanced treatment with negative modulators of the drug-resistant protein survivin. American Journal of Translational Research. 1: 393-405 |
| Wu J, Apontes P, Song L, et al. (2007) Molecular mechanism of upregulation of survivin transcription by the AT-rich DNA-binding ligand, Hoechst33342: evidence for survivin involvement in drug resistance. Nucleic Acids Research. 35: 2390-402 |
| Wu J, Ling X, Pan D, et al. (2005) Molecular mechanism of inhibition of survivin transcription by the GC-rich sequence-selective DNA binding antitumor agent, hedamycin: evidence of survivin down-regulation associated with drug sensitivity. The Journal of Biological Chemistry. 280: 9745-51 |
| Li F, Ling X, Huang H, et al. (2005) Differential regulation of survivin expression and apoptosis by vitamin D3 compounds in two isogenic MCF-7 breast cancer cell sublines. Oncogene. 24: 1385-95 |